Tarsus Pharmaceuticals (TARS) Net Income (QoQ) (2019 - 2026)
Tarsus Pharmaceuticals (TARS) Net Income (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,320.50 Bn | 66,320.21 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.93 Bn | 468.14 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.22 Bn | 114.98 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.96 Bn | 61.21 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 56.07 Bn | 50.89 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.60 Bn | 34.59 Bn | 959.66 Mn |
| 10 | Tarsus Pharmaceuticals | 2.62 Bn | 2.52 Bn | 152.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.03% |
| Dec 31, 2025 | 50.80% |
| Sep 30, 2025 | 89.75% |
| Jun 30, 2025 | -393.99% |
| Mar 31, 2025 | -8.23% |
| Dec 31, 2024 | 1.50% |
| Sep 30, 2024 | 24.92% |
| Jun 30, 2024 | 12.01% |
| Mar 31, 2024 | 16.28% |
| Dec 31, 2023 | -9.01% |
| Sep 30, 2023 | -24.01% |
| Jun 30, 2023 | -34.56% |
| Mar 31, 2023 | -78.16% |
| Dec 31, 2022 | 41.70% |
| Sep 30, 2022 | -310.77% |
| Jun 30, 2022 | 72.42% |
| Mar 31, 2022 | -36.79% |
| Dec 31, 2021 | 5.56% |
| Sep 30, 2021 | -314.17% |
| Jun 30, 2021 | -30.40% |